CARL L GORDON Transaction History

Date Transaction Value Shares Traded Form
Jul 16 2024
SELL
Open market or private sale
$51,880 $10.0 p/Share
5,188
Jul 15 2024
SELL
Open market or private sale
$509,760 $10.0 p/Share
50,976
Dec 23 2022
BUY
Open market or private purchase
$999,999 $7.25 p/Share
137,931
Aug 16 2022
BUY
Open market or private purchase
$8,929,800 $2.42 p/Share
3,690,000
Feb 09 2021
BUY
Conversion of derivative security
-
3,316,204
Feb 09 2021
BUY
Open market or private purchase
$8,075,000 $17.0 p/Share
475,000

Also insider at

TPTX
Turning Point Therapeutics, Inc.
KNTE
Kinnate Biopharma Inc. Healthcare
PRVL
Prevail Therapeutics Inc.
ACET
Adicet Bio, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
KROS
Keros Therapeutics, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
THRX
Theseus Pharmaceuticals, Inc. Healthcare
CMPX
Compass Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
MBX
MBX Biosciences, Inc.
CLG

Carl L Gordon

Director
San Diego, CA

Track Institutional and Insider Activities on TERN

Follow Terns Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

News

Receive news related to Terns Pharmaceuticals, Inc.

Track Activities on TERN